• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

DF/HCC News

    Breakefield awarded $5.8 million to study tumors

    DF/HCC member Xandra Breakefield, PhD (MGH) will receive approximately $5.8 million in total costs over five years to study the genetic and cellular factors contributing to the formation and progression of benign tumors in the nervous system

    Harvard receives transforming NIH award

    Harvard Medical School has been awarded the Clinical and Translational Science Award (CTSA) from the National Institutes of Health

    DePinho awarded $10.8 million to study malignant gliomas

    DF/HCC member Ronald DePinho, MD (DFCI) has successfully renewed funding from the NCI to better understand the pathogenesis of glioblastoma multiforme (GBM)

    Two DF/HCC members honored at ASCO annual meeting

    Jay Harris, MD (DFCI) and Bruce Johnson, MD (DFCI) were honored at the 2008 meeting of the American Society of Clinical Oncology (ASCO) for their outstanding accomplishments in cancer research

    (CF) RMS cells invade into adjacent muscle (C), intestine (D), liver (E), and kidney (F). Dotted line in D outlines the outer edge of effaced intestine. Arrowheads denote striated muscle tumors. The boxed region in E is a magnified view of a striated cell in the liver. Bars: CF, 50 m.
    Specialized Histopathology Services Core

    The Specialized Histopathology Services (SHS) Core provides technical and professional pathology services in a variety of experimental organisms and human tissues

    High-Throughput Polymorphism Detection Core

    The High-Throughput Polymorphism Detection Core provides services to investigators conducting molecular analyses of somatic DNA collected as part of a wide range of investigations

    Harvard receives transforming NIH award

    Harvard University has become a members of the NIH's Clinical and Translational Science Award consortium

Displaying results 148 to 154 out of 216